Magnesium Replenishment in Magnesium Deficiency
For patients with magnesium deficiency, oral magnesium oxide (12-24 mmol daily) is recommended as first-line therapy, with intravenous magnesium sulfate (1-2g every 6 hours or up to 5g over 3 hours for severe cases) reserved for patients with severe deficiency, malabsorption, or inability to tolerate oral supplementation. 1
Diagnosis of Magnesium Deficiency
- Serum magnesium level <1.5 mEq/L typically indicates deficiency
- Important caveat: Normal serum magnesium may still occur with intracellular magnesium depletion 2, 3
- Clinical manifestations suggesting deficiency:
- Neuromuscular hyperexcitability
- Cardiac arrhythmias
- Concurrent hypokalemia and hypocalcemia that are refractory to supplementation
- Fatigue, muscle cramps, bone pain, impaired healing 1
Treatment Algorithm
Step 1: Assess Severity and Route of Administration
Mild to Moderate Deficiency:
- Oral supplementation is first-line therapy 1, 4
- Magnesium oxide: 12-24 mmol daily (typically given at night when intestinal transit is slowest) 1
- Organic magnesium salts (aspartate, citrate, lactate) have better bioavailability than oxide or hydroxide forms 1
Severe Deficiency or Malabsorption:
- Intravenous therapy is indicated 1, 5
- Initial dosing: 1-2g (8-16 mEq) IV every 6 hours for four doses 5
- For severe hypomagnesemia: up to 5g (40 mEq) added to 1L of 5% dextrose or 0.9% sodium chloride for slow infusion over 3 hours 5
- Maximum rate of IV administration: 150 mg/minute 5
Step 2: Address Underlying Causes
- Correct water and sodium depletion to reduce secondary hyperaldosteronism 1
- For GI losses (common in IBD, short bowel syndrome):
Step 3: Monitoring and Maintenance
- Monitor serum magnesium levels regularly
- For patients with short bowel syndrome or jejunostomy:
Special Considerations
Route-Specific Considerations
Oral supplementation:
Intravenous supplementation:
- Advantages: Rapid correction, bypasses GI absorption issues
- Disadvantages: Requires IV access, risk of hypermagnesemia
- Contraindicated in severe renal insufficiency without careful monitoring 5
Subcutaneous administration:
- Can be used if IV access is difficult
- Typically 4 mmol magnesium sulfate added to subcutaneous saline 1
Disease-Specific Considerations
Short Bowel Syndrome/Jejunostomy:
Inflammatory Bowel Disease:
Bartter Syndrome:
Common Pitfalls to Avoid
Relying solely on serum magnesium levels - Normal levels may mask intracellular deficiency 2, 3, 6
Failure to correct concurrent electrolyte abnormalities - Hypomagnesemia often coexists with hypokalemia and hypocalcemia 2, 3
Inadequate monitoring in renal insufficiency - Maximum dosage should not exceed 20g/48 hours with frequent monitoring 5
Single large doses of oral supplements - Causes rapid changes in blood levels and may worsen GI symptoms; divide into multiple daily doses 1
Overlooking underlying causes - Addressing the root cause (GI losses, medications, etc.) is essential for successful treatment 3